✦ LIBER ✦

A phase 1 and pharmacokinetic study of TAS-106 administered weekly for 3 consecutive weeks every 28 days in patients with solid tumors

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacologic study of diflo

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

550 Phase I and pharmacokinetic (PK) stu

✍ S.Q. Chu; G. Schwartz; M. Beeram; A. Patniak; M. Mita; J. Jimeno; L. Lopez-Laraz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Phase I dose-escalation study of vinflun

✍ Calvo, E.; Vermorken, J. B.; Hiret, S.; Rodon, J.; Cortes, J.; Senellart, H.; de 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 242 KB

A phase I trial of topotecan and gemcita

✍ Weijing Sun; James P. Stevenson; Maryann Gallagher; Bruce Giantonio; Kenneth Alg 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

A phase I study of bendamustine hydrochl

✍ Rasschaert, M; Schrijvers, D; Van den Brande, J; Dyck, J; Bosmans, J; Merkle, K; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase I study of cisplatin, irinotecan,

✍ Chen, X; Oza, A M; Kusenda, Z; Yi, Q-L; Kochman, D; Moore, M J; Davis, A J; Siu, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB